Bafiertam (Monomethyl fumarate) for Multiple Sclerosis | MyMSTeam

Connect with others who understand.

sign up Log in
About MyMSTeam
Powered By

Bafiertam is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting MS, and secondary progressive MS. Bafiertam is also referred to by its drug name, monomethyl fumarate.

Bafiertam is a member of a class of drugs called fumaric acid derivatives. The exact way Bafiertam works is unknown. Bafiertam is believed to work by reducing inflammation and protecting body cells.

How do I take it?
Prescribing information states that Bafiertam is given orally twice per day.

Bafiertam comes as a delayed-release capsule.

Side effects
The FDA-approved label for Bafiertam lists common side effects including flushing, abdominal pain, diarrhea, and nausea.

Rare but serious side effects listed for Bafiertam include severe allergic reactions, serious infections including a rare brain infection called progressive multifocal leukoencephalopathy (PML), low white blood cell count, and liver damage.

For more details about this treatment, visit:

Bafiertam (Monomethyl Fumarate) — Banner Life Sciences

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in